The following immunohistochemistry revealed that HMGB1 was translocated from the nucleus to the cytoplasm of the BNCT-treated tumor cells (Figures 19B-C), indicating that its release was associated with cell death. The gene discussed is HMGB1; the disease is neoplasm.